Exclusive | Anthropic Adds Novartis CEO to Board
Anthropic has appointed Vas Narasimhan, chief executive of Swiss pharmaceutical company Novartis NOVN 0.56%increase; green up pointing triangle,…
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Novartis Pharma AG Shareholders approve 29th consecutive dividend increase to CHF 3.70 (+5.7%) per share for 2025, representing…
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Novartis Pharma AG Shareholders approve 29th consecutive dividend increase to CHF 3.70 (+5.7%) per share for 2025, representing…
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Novartis Pharma AG Shareholders approve 29th consecutive dividend increase to CHF 3.70 (+5.7%) per share for 2025, representing…
Zurich raises SFr3.9bn to support Beazley takeover
Zurich Insurance Group has raised SFr3.9bn through an accelerated book-building to partly finance its proposed acquisition of UK-based…